Allergan Breast Implant MDL 2921 Case Management Orders (CMOs)
All case management orders (CMOs) for the Allergan Biocell breast implant lawsuits consolidated in MDL 2921.
MDL 2921 Allergan Breast Implant Case Management Orders
Below are links to each case management order in MDL 2921 for the Allergan Biocell breast implant lawsuits. MDL 2921 has been in existence since December 2019 and there are now numerous case management orders on file. Staying current with the Allergan breast implant case management orders is a good way to stay up to date on the status of MDL 2921. Bookmark this page, as Allergan breast implant case management orders are added once they have been entered on the docket for MDL 2921.
-
08/10/2026 Case Management Order No. 43 (Modification of Appointments to the Plaintiffs’ Steering Committee)PDF
-
04/30/2026 Case Management Order No. 39 – Modification of Appointments to the Plaintiffs’ Steering CommitteePDF
-
09/10/2025 Case Management Order No. 35 – 2026 Case Management Conference Schedule & Dial-In ProceduresPDF
-
05/19/2025 Case Management Order No. 33 – Modification of Appointments to the Plaintiffs’ Steering CommitteePDF
-
01/08/2025 Amended Case Management Order No. 31 – 2025 Case Management Conference Schedule & Remote ProceduresPDF
-
05/16/2024 Case Management Order No. 30 – Extension of Bellwether Selection and Core Discovery DeadlinesPDF
-
05/13/2024 Case Management Order No. 29 – 2024 Case Management Conference Schedule & Dial-In ProceduresPDF
-
10/05/2023 Case Management Order No. 27 – Modification of Appointments to the Plaintiffs’ Steering CommitteePDF
-
08/01/2022 Case Management Order No. 25 – Modification of Appointments to the Plaintiffs’ Steering CommitteePDF
-
11/13/2020 Case Management Order No. 19 – Oral Argument Scheduling & Time Limits for Motions to DismissPDF
-
09/15/2020 Case Management Order No. 18 – Proper Party Defendant Stipulation & Dismissal of Related EntitiesPDF
-
08/19/2020 Case Management Order No. 14 – August CMC Summary, Short Form Complaint Directives & 2021 PlanningPDF
-
05/22/2020 Case Management Order No. 11 – Science Day Ground Rules & Educational Presentation SchedulePDF
-
05/19/2020 Case Management Order No. 10 – May CMC Summary, Master Complaint & Rule 12(b)(6) Briefing DeadlinesPDF
-
04/20/2020 Case Management Order No. 9 – April CMC Summary, Master Complaint Deadlines & Discovery StayPDF
-
03/23/2020 Case Management Order No. 8 – Service of Fact Sheets & Medical Authorizations through MDL CentralityPDF
-
08/19/2020 Amended Case Management Order No. 6 – Direct Filing Procedures & Presumptive Place of RemandPDF
-
03/16/2020 Case Management Order No. 5 – March CMC Summary, Oral Argument Scheduling & Procedural DirectivesPDF
-
02/25/2020 Case Management Order No. 4 – Appointment of Plaintiffs’ Leadership Counsel & Steering CommitteePDF
Allergan Breast Implant Lawsuit MDL 2921 Information
For more information on the status of MDL 2921, check out our page on the Breast Implant Lawsuit. For more information on the recall and specific symptoms, see the details below.
Why is the FDA recalling the Allergan Biocell breast implants?
The Food and Drug Administration (FDA) has issued a recall for all textured saline-filled breast implants manufactured by Allergan, Inc. The recall comes after reports of a rare cancer called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). In addition to the textured saline-filled breast implants, Allergan has also recalled one of their textured silicone gel filled breast implants.
What is BIA-ALCL?
BIA-ALCL is a rare form of lymphoma that develops around breast implants after they are placed. The lymphoma is an aggressive type of cancer that can spread quickly throughout the body and become life threatening if left untreated. In some cases, patients who develop BIA-ALCL may require chemotherapy or radiation therapy to treat the disease.
Signs & Symptoms of BIA-ALCL
This form of ALCL often begins with symptoms similar to those of other lymphomas, including:
- Painless swelling in one or both breasts
- Swelling around the neck or underarm area (lymph nodes)
- Fever and night sweats (persistent high temperature)
- Loss of appetite or weight loss
How is BIA-ALCL Diagnosed?
The FDA has recommended that women with textured breast implants undergo a CT scan of the chest and abdomen. This is because it can be difficult to distinguish between BIA-ALCL and other forms of lymphoma, such as SLL/CLL or FL. A biopsy of one or more lesions may also be performed in order to confirm the diagnosis.
